#Novacyt more than COVID-19 🔬

🔎 550 non COVID range

. Human pathogen
. Veterinary
. Food, water & agriculture
. Bio threats
. Genotyping

Find out in April how #NCYT will leveraging it's role within 🇬🇧 diagnostics infrastructure

#ALNOV #Primerdesign
#Novacyt's Genesig tests are designed to run on the q16 & larger q32 which is one of the fastest qPCR instruments in the world

I'm looking forward to seeing ProMATE being adapted to further simplify #NCYT testing base
#Novacyt have a Massive range of Respiratory Infection detection kits

& as demonstrated by COVID they are fast to react to new threats

& now UK has the tools & political will to test

#Novacyt #ALNOV #NCYT #Primerdesign
#NCYT testing

Sexually transmitted infections 🥵

Transplant & Immunosuppressed ✅

Hepatitis ✅

Human papillomavirus ✅

Meningitis ✅

Early detection results in better patient outcomes 💙

More cost effective for health providers & Governments

#Novacyt #Primerdesign
So many #Novacyt tests to digest.

The #NCYT strategy being annouced end of April will explain how the company will leverage it's new position post COVID

. Gastrointestinal infections 🤢

. Vector born-diseases 🦟 (imagine it's a mosquito)

#Primerdesign
#ALNOV
#Primerdesign

. Multiplex tests 🤹‍♂️ (multiple targets)

. Peridontal infections 🦷😣

. Human parasites 🦠

#Novacyt #ALNOV #NCYT
Protection of our environment & food chain is critical #NCYT have the tests

. Food 🍗

. Water 💦

. Agriculture 🚜

#Novacyt #ALNOV #Primerdesign
No one wants a spoilt pint #Primerdesign

As we come out of lockdown #NCYT's 🍻🍺🍻 will keep us safe & hydrated

#Novacyt #ALNOV
Ace #Novacyt pet 🐶🐱🐎🐑🐦🐑 Detective 🕵️‍♀️

#Novacyt #ALNOV #Primerdesign
Find the bug, treat the bug #Novacyt

. CEMO 🐴
. K Pneumoniae 💩🦠🔁
. P. aeruginosa 🧫🌱🥬💦 👨‍👩‍👧‍👦

#NCYT #ALNOV #Primerdesign
Bio ☣ threats & Coronavirus are high on the world leaders major threat lists

#Novacyt #ALNOV #ALNOV

Governments need to be prepared

#Primerdesign
#Novacyt will design a prime test for you "On demand"

#NCYT #ALNOV #Primerdesign
#Novacyt are always improving their "Easy Extraction kits" as demonstrated by recent advancements with ProMATE & HT-Direct
#NCYT #ALNOV #Primerdesign
#Novacyt provide you with a "Lab-in-a-Box"

with ProMATE & q's you can have a lab on your desk #NCYT #ALNOV #Primerdesign

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with New Forms Research

New Forms Research Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @NewFormsResearc

7 Mar
Some PCR investor stress caused by reissue of LFT Tender

It's value was cut by 2/3rd's

£8b down from £20b

Bids submitted by 7th April

Add on bid evaluation period

& 30 days contact standstill / freeze period

#Novacyt #Microgen compete for both

bidstats.uk/tenders/2020/W…
Is #Novacyt taking off 🛫?
Read 5 tweets
15 Feb
BCG analyzed 🔬 🇺🇸, 🇫🇷 , 🇩🇪 , 🇮🇹, 🇪🇸 Outlook

Testing's likely to follow similar trajectories

Peak COVID demand occurring in the seasonally affected first quarters of 2021 & 2022

#Novacyt #ALNOV #NCYT

bcg.com/en-in/publicat…
BCG anticipate continued need for testing in 2023 & 2024

Even if vaccines prove to be highly effective, the need to test people for COVID-19 will continue, for at least five reasons

#Novacyt #ALNOV #NCYT
TESTING DEMAND DRIVERS:

. Epidemiology of the COVID-19 🧬
. Impact of the vaccines 💉
. Impact of therapeutics 💊
. Government policy 📜

What makes a good test 🔍
#Novacyt #ALNOV #NCYT
Read 5 tweets
12 Feb
Don't you wonder sometimes
About genes and vision?

#Novacyt #ALNOV #NCYT

“Our SNPsig assays are the same high level of accuracy as our PCR SARS-CoV-2 portfolio,” Mullis said. More variants will be added as they are identified.

ImageImage
“primary challenge for COVID-19 diagnostics companies is ensuring their products continue to accurately test for the virus, regardless of the variant, and to innovate at the challenging pace required to remain clinically relevant"

Graham Mullis #Novacyt

bioworld.com/articles/50347…
🔬👩🏻‍🔬#Novacyt👨‍🔬🔬

#NCYT launched PCR genotyping assay portfolio to detect COVID-19 variants

#ALNOV The SNPsig portfolio is designed to run on central laboratory systems & on the company’s q16 and q32 rapid PCR systems
Read 7 tweets
11 Feb
Prof Sharon Peacock Cambridge Uni, her work sequencing variants may be required for at least 10 yrs

bbc.co.uk/news/uk-560199…

#Novacyt #ALNOV #NCYT
(April) Novacyt Partners With AstraZeneca, GSK, University Of Cambridge To Increase COVID-19 Testing

#Novacyt #ALNOV #NCYT
Read 13 tweets
9 Feb
When the ship sways you don't jump into waters where sharks lurk #LFT's

Jump out of a plane during turbulence

Not me 😎 plane sailing
#SureScreen #LFT💩

"now in their final stage of validation in clinical trials" NOT APPROVED

"sensitivity against high viral loads" 💩🔬

#MattHancock Daily Briefing (08/02/21) test detects 1/3 cases

gov.uk/government/new…

Who's life would you risk?

#Novacyt #PCR 🔬🏅☑️
COVID Antigen LFT validation prioritisation criteria update (8/02/21)

SureScreen were awarded direct tender on 8th. Could struggle to diagnose asymptomatics, test only detects "High viral loads"?

@GoodLawProject @JolyonMaugham @Independent

gov.uk/guidance/later…
Read 7 tweets
8 Feb
UK micro > small cap 🔬 snap shot

#Novacyt
Sales - £277m
Cash - £92m
COVID prods on sale - 10+
Market Cap - £565m

#Abingdon, #BBI, #Omega, #Avacta, #GeneDrive (#GDR) & #Yourgene

Sales - £28m > £30m (Yourgene £18>£20m)
Cash - 🤔
COVID prods on sale - 3🤔
Market Cap - £761m Image
There's a margin of error to account for BBI accounts which aren't public, awaiting GeneDrive which reports 31/03, Avacta account were published 23/01 last yr.

Say £5m tops. Small fry when you consider imbalance of collective market capitalisations.
AIM 2020 Top % Risers (cash / Mcap)
#NCYT - £91.8m / £553m
#AAA - £10.2m / £204m
#SNG - £10.9m / £305m
#GGP - £6m / £983m
#EQT - €1.7m / £156m
#SVE - £118k / £13m
#EUA - £50.8k / £759m
#MNO - £1.43m / £25m
#PHE - £5m / £306m
#OMI - £7.6m / £51m

*info as per latest relevant RNS Image
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!